Dermatitis atopic
Not recruitingStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
- Disease:Dermatitis atopic
- Substances:Rocatinlimab
Spain- Participants:18–64 years · 65+ years
- Substances:Rocatinlimab
- Sponsor:Amgen Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain69 clinical trials in Manises, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on plaque psoriasis and atopic dermatitis, evaluating new therapeutic approaches for moderate to severe cases.
Multiple studies investigating novel compounds and treatment options for chronic skin conditions.
Comprehensive research into hidradenitis suppurativa, examining various therapeutic agents for managing this challenging condition.
Studies aim to improve quality of life for patients with chronic inflammatory conditions.
Research targeting specific conditions including prurigo nodularis, vitiligo, and chronic spontaneous urticaria.
Focused investigations on targeted treatments for specific dermatological conditions.
Studies examining treatments for heart failure and related conditions, with emphasis on combination therapies and patient outcomes.
Investigations into improving cardiovascular health through innovative treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.